STPI

menu¢x¥»«Ç²¤¶¢x­«¤j²£·~¬Fµ¦¢x²£·~·s»D¢x¥«³õ³ø¾É¢x²£·~µ¦²¤µûªR¢x±M§Q±¡³ø¢x§Þ³N±¡³ø¢x
menu¢x¼öÂI±MÃD¢x½Õ¬d³ø§i ¢xÀ]Âò£·~³ø§i¢xÃöÁä¹Ïªí¢x­q¹q¤l³ø¢xªA°È¤º®e¢xSTPI­º­¶¢x
 
±M§Q±Ð«Ç
Åwªï±À¤å¡G facebook plurk twitter

¡½ ²£¾Ç¦X§@®×¨Ò¡GBioTechnology±±§iCiba Vision±M§Q«IÅv¤ÎDrexel¤j¾Ç¥¼¼i¦æ¦X¬ù

¤@¡B¶D³^®×¥ó·§­z

BioTechnology¤½¥q©ó2009¦~8¤ë28¤é¦VªF»«¦{Áp¨¹¦a¤èªk°|¡A´£°_¹ïCiba Vision¤½¥q±M§Q«IÅv¡A¥H¤ÎDrexel¤j¾Ç¥¼¼i¦æ¦X¬ùªº¶D³^¡C°_¶D®Ñ¤¤«ü¥XCiba Vision¤½¥q«I®` US5,080,924¡BUS5,260,093¡BUS5,326,584»PUS5,578,079µ¥¥|¥ó±M§Q¡A¦Ó³o¨Ç±M§Q¬O¥ÑDrexel¤j¾Ç»POphthalmic Research Corporation(ORC)¦@¦P¾Ö¦³(Joint Ownership)ªº¡C¨Ã©ó¶Dª¬¤¤¡A«ü¥X³Q§i¼t°Ó¬ÛÃö¤§«IÅv²£«~¸ê°T(°Ñ¨£www.us.cibavision.com)¡C

¥»¦¸¶D³^¯S¦â¤§¤@¬°Drexel¤j¾Ç¤@¤è­±¬°«D¦ÛÄ@©Ê­ì§i(Involuntary Plaintiff)¡A¦P®É¤]¬O³Q§i(Defendant)¡A¦]¬°»PBioTechnology¦@¦³¨tª§±M§Q©Ò¦³Åv¤§¬G¡C

ªí¤@¡B±M§Q¶D³^®×¥ó°ò¥»¸ê®Æ·J¾ã

´£§i¤é´Á

2009¦~8¤ë28¤é

­ì§i

BioTechnology, LLC

³Q§i

CibaVisionCorporation
DrexelUniversity

¦aÂI

United States District Court ¡VFor the Eastern District ofPennsylvania
ªF»«¦{Áp¨¹¦a¤èªk°|

®×¸¹

2:09-cv-03947-BMS

¨tª§±M§Q

US5,080,924 (Method of Making Biocompatible, Surface Modified Materials)

US5,260,093 (Method of Making Biocompatible, Surface Modified Materials)

US5,326,584 (Biocompatible, Surface Modified Materials of Making the same)

US5,578,079 (Biocompatible, Surface Modified Materials)

¸ê®Æ¨Ó·½¡G ¾G·ß¶W¡A¬ì§Þ¬Fµ¦¬ã¨s»P¸ê°T¤¤¤ß¡X¬ì§Þ²£·~¸ê°T«Ç¾ã²z¡A2009/09

ªí¤G¡B¨tª§±M§Q

Publication Title Assignee Pub. Date Filed Priority IPC Code
US5080924  Method of making biocompatible, surface modified materials Drexel University  1992-01-14   1989-04-24   1989-04-24  A61L 27/34
US5260093  Method of making biocompatible, surface modified materials Drexel University  1993-11-09   1992-01-13   1989-04-24  A61F 2/16
US5326584  Biocompatible, surface modified materials and method of making the same Drexel University  1994-07-05   1992-11-18   1989-04-24  A61F 2/16
US5578079  Biocompatible, surface modified materials Drexel University  1996-11-26   1993-04-14   1989-04-24  A61F 2/16

 

¤G¡B¨tª§±M§Q©Ò¦³Åvª¬ªp¸ÑªR

±M§Q¦@¦³ªº±¡ªp¤U¡A¥²¶·©Ò¦³±M§Q¦@¦³¤H¦@¦P°Ñ»P¶D³^¡A¥H§K¤@­Ó«IÅv¦æ¬°¤Þµo¨â­Ó¥H¤W¬Û¦P¤º®eªº¶D³^¡C¦b¤í¯Ê¥þ³¡¦@¦³¤H°Ñ¥[¶D³^ªº±¡ªp¤U¡A±MÄݳQ±ÂÅv¤H(Exclusive Licensee)©Î³¡¤Àªº±M§Q¦@¦P«ù¦³¤H(¦pORC)¡AµLªk³æ¿W¦¨¬°­ì§i¡A­ì«h¤W¥²¶·¦@¦³±M§QÅv¤Hªº°Ñ¥[¡A©l¦³¹ï«IÅv¤H´£°_¶D³^¤§·í¨Æ¤H¾A®æ¡C¹ï©ó¥¼°Ñ¥[¶D³^ªº±M§Q¦@¦³¤H¡A¥²¶·¨ú±o¨ä¤¹³\¡A©Î¬O±N¨ä¦C¬°«D¦ÛÄ@©Ê­ì§i(Involuntary Plaintiff)¡A¥H²Å¦X¶D³^·í¨Æ¤H¾A®æ¤§­n¥ó¡C

Drexel¤j¾Ç¦P®É¨­³B³Q§i»P­ì§i¤§Âù­«¨­¤À¡A«Y¦]¬°¦¹¦¸¶D³^¤§4¥ó¨tª§±M§Q¬Ò¬°Drexel»PBioTechnology¦@¦P¾Ö¦³¡C®Ú¾Ú¸Ó®Õ»PORC(¨ä«á³QBioTechnology¨ÖÁÊ)©ó1984¦~©Òñ­q¤§¦@¦P¬ã¨s¤è®×¨óij(Joint Research Program Agreement)«ü¥X¡A©Ò¦³¬ÛÃöªºµo©ú¡A¬Ò¥ÑDrexel»PORC©Ò¦@¦P¾Ö¦³¡AÂù¤è¨ã¦³¬Ûµ¥(Equal)¡B¤£¥i¤À³Î(Undivided)¡A¥H¤Î¦U¥bªº§Q¯q(One-half Interests)¡C¦X¬ù¤¤¶i¤@¨B©w¸q¡uµo©ú¡vªº½d³ò¡G¥]§t¥ô¦óµo©ú¡Bµo²{¡B§ï¶i¡AµL½×¬O§_¥i±M§Q©Ê(Patentable)¬ÒÄݤ§¡C¸Ó¨óij¹ï©ó±M§Q¥Ó½Ð¹Lµ{¥H¤Î¥¼¨Ó¥i¯àµo¥Í¶D³^®É¡ADrexel¥²¶·¥R¤À°t¦XORCªº¬ÛÃö­n¨D(to corporate fully with ORC)¡C

¦ý¬O¦b¶i¦æ¦h¦¸½R°Ó¤§«á¡AÂù¤è¤´µLªk¹F¦¨¨óij¡CBioTechnology©ó´£°_¶D³^®É¤@¨Ö±NDrexel¦C¬°³Q§i¡A±±§i¸Ó¤j¾Ç¥¼¼i¦æ¦X¬ù¤§¸q°È¡C

ªí¤T¡B±M§Q©Ò¦³Åvµo®i¨Æ¥óªí

¤é´Á

¨Æ¥ó

1984.3.5

Drexel»PORCñ­q¦@¦P¬ã¨s¤è®×¨óij(Joint Research Program Agreement)

2004.3.16

ORC³QBio-Cellular, LLC ¨ÖÁÊ

2008.12.17

Bio-Cellular±NORC©Ò¾Ö¦³ªº±M§Q²¾Â൹BioTechnology¡]¥]¬A»PDrexel¦@¦³¤§±M§Q¡^

2009.6.10

Bio-Cellular³QBioTechnology¨ÖÁÊ

2009.5.19~ 2009.7.6

Drexel»PBioTechnologyÂù¤è«ß®v¦h¦¸¹ï©ó¦VCiba Vision¤½¥q´£°_¶D³^¶i¦æ¨ó°Ó¡A­n¨DDrexel¼i¦æ¦@¦P¶D³^¤§¸q°È

2009.8.28

Âù¤è¨ó°Ó¯}µõ¡ABioTechnology±NDrexel¦C¬°³Q§i

¸ê®Æ¨Ó·½¡G¾G·ß¶W¡A¬ì§Þ¬Fµ¦¬ã¨s»P¸ê°T¤¤¤ß¡X¬ì§Þ²£·~¸ê°T«Ç¾ã²z¡A2009/09

¤T¡B¶D¤§Án©ú

  • (¤@)½Ð¨Dªk°|½T»{³Q§iCiba Vision¤½¥qªº²£«~«I®`US5,080,924¡BUS5,260,093¡BUS5,326,584»PUS5,578,079µ¥¥|¥ó±M§Q¡F
  • (¤G)½Ð¨Dµ¹¤©BioTechnology¦]Ciba Vision«IÅv©Ò³y¦¨ªº¹ê»Ú·l®`½ßÀv¡A¨Ã¥B©Ò±o¤§½ßÀv¤£±o¤Ö©ó¦X²zªºÅv§Qª÷¡F
  • (¤T)µ¹¤©¥Ã¤[©Î¬O¼È®Éªº¸T¨î¥O¡A¸T¤îCiba Visionª½±µ«I®`¡B»²§U«I®`¥H¤Î»¤¤Þ«I®`¥ÑBioTechnology©Ò¾Ö¦³ªº¥|¥ó±M§Q¡F
  • (¥|)§P¨MCiba Vision¬G·N«I®`¤W­z¥|¥ó±M§Q¡A¨Ã¥Bµ¹¤©BioTechnology·l®`ÃB«×³Ì°ª¦Ü¤T­¿ªºÃg»@©Ê½ßÀvª÷¡F
  • (¤­) ½Ðªk°|½T»{¦¹®×¥ó¬°¬ü°ê±M§Qªk²Ä285±ø¤§¯S®í(Exceptional)±¡¨Æ¡A³Q§iÀ³µ¹¥I«ß®v¶O¤Î¶i¦æ¥»¶D³^§P¨M«e«á©Ò­l¥Í¥Xªº§Q®§¶O¥Î¡F
  • (¤»)§P¨MDrexel¤j¾Ç¹H­I·íªì©Òñ­q¤§¦@¦P¬ã¨s¤è®×¨óij¡F
  • (¤C)§P¨MDrexel¤j¾ÇÄY­«¹H¤Ï(material breach)¬ã¨s¨óij¡F
  • (¤K)§P¨M¸Ó¬ã¨s¨óijµL®Ä¡A§K°£¤@¤ÁBioTechnology©ÒÀ³­t¾á¤§¸q°È¡F
  • (¤E)©R¥ODrexel¤j¾Ç¥²¶·¼i¦æ¸q°È»PBioTechnology¦X§@¦æ¨Ï¨tª§±M§Q¤§Åv§Q¡F
  • (¤Q)µ¹¤©¥Ã¤[©Î¬O¼È®Éªº¸T¨î¥O¡G
  • 1. ¸T¤î»PDrexel¤j¾Ç¦³Ãö¤§¤H¤h¡AÄ~Äò±N¤W­z±M§Q±ÂÅvµ¹¨ä¥L¤H
  • 2. ­n¨DDrexel¤j¾ÇÂkÁÙ©Ò¦³»PBioTechnology¬ÛÃö¤§¤å¥ó(¥]§tÀÉ®×»P¬ÛÃö¹q¤lÀx¦s¨t²Î)
  • (¤Q¤@)§P¨M¦]¬°Drexel¤j¾Ç¥¼¼i¦æ¦X¬ù¹ïBioTechnology©Ò³y¦¨¤§·l®`¡F
  • (¤Q¤G)ªk°|»{¬°­ì§i¥i¥HÀò±o¨ä¥L¤½¥­¦X²zªº±ÏÀ٤覡¡C

(1385¦r¡Aªí¡G2)

ÃöÁä¦r¡G±M§Qµ¦²¤§G§½¡F±M§Q¶D³^®×¡F±M§Q«IÅv¡FBioTechnology, LLC¡FCiba Vision Corporation¡FDrexel University¡F«D¦ÛÄ@©Ê­ì§i(Involuntary Plaintiff)¡F±MÄݳQ±ÂÅv¤H(Exclusive Licensee)¡FOphthalmic Research Corporation(ORC)¡F¦@¦P¾Ö¦³(Joint Ownership)¡F¦@¦P¬ã¨s¤è®×¨óij(Joint Research Program Agreement) ¡F²£¾Ç¦X§@

(¬ì§Þ²£·~¸ê°T«Ç--¥æ³q¤j¾Ç¬ì§Þªk«ß¬ã¨s©Ò¼B©|§Ó±Ð±Â¹Î¶¤¼¶½Z¡A2009/09/28)

 
«e´Á¸ê®Æ¡G
³Õ³q¤½¥q¹ïEmulex´£°_°ª³t¸ê°T»PÀx¦sºô¸ô§Þ³N±M§Q«IÅv¶D³^
2009/09/18
2009/09/17
2009/09/14
3G§Þ³N±M§Q¶D³^¡A¿D¬wCSIRO±±§i¦h®aPC¤j¼t
2009/09/10
¦h¤áµø°T·|ij§Þ³N±M§Q¶D³^¡A´f´¶Halo²£«~¤Î¨Ï¥Î«È¤á®Á§i
2009/09/09
Eppendorf©ó¬ü°êªk°|¹ïNanosphere´£°_¥Íª«´¹¤ù±M§Q«IÅv¶D³^
2009/09/03
DRAM¹q·½ºÞ²z´¹¤ù¶D³^¦a¹Ï¡G¦w´Ë¬ü¥b¾ÉÅé±±§i¤T¬P¡B®ü¤O¤h¡B«n¨È¬ì¡Bº¸¥²¹F¡BHittite
2009/09/02
²G´¹¹qµø¶D³^¦a¹Ï¡G®L´¶¡B¤T¬P¡B¤Í¹F¡BLG 2009/08/28
·L³n¦V¬ü°êÁp¨¹¨µ°j¤W¶Dªk°|½Ð¨D©µ«á°õ¦æI4I³Ó¶D¤§¥Ã¤[¸T¨î¥O
2009/08/26
·L³n«I®` I4I ±M§Q¡G2003 »P2007 WORD²£«~¸T¤î³c°â
2009/08/20
¬ü°êITCªì¨B»{©w¿Õ°ò¨È¥¼¹H¤ÏInterDigital¤½¥q3G±M§Q
2009/08/19
Wi-Fiºô¸ô¤½¥qBandspeed´£§i¯Á¥§¡B¥ô¤Ñ°ó¤ÎÄ«ªG¤½¥q±M§Q«IÅv
2009/08/13
2007-2009²G´¹¹qµø¶D³^¦a¹Ï¡GVizio¡B²î¤«¡B¯Á¥§¡BLG
2009/08/13

... more


IJ±±À³¥Î§Þ³N»P¥«³õ ±M¿è
IJ±±­±ªO(Touchscreen Panel)©ó¬ü°ê±M§Q¶D³^½Õ¬d
³n©ÊÅã¥Ü¾¹§Þ³N¤ÎÀ³¥Î±MÃD

¡iÁn©ú¡j
1. ¬ì§Þ²£·~¸ê°T«Ç¥Z¸ü¦¹¤å¤£¥Nªí¦P·N¨ä»¡ªk©Î´y­z¡A¶È¬°´£¨Ñ§ó¦h°T®§¡A¤]¤£ºc¦¨¥ô¦ó§ë¸ê«ØÄ³¡C
2. µÛ§@Åv©Ò¦³¡A«D¸g¥»ºô¯¸®Ñ­±±ÂÅv¦P·N¤£±o±N¥»¤å¥H¥ô¦ó§Î¦¡­×§ï¡B½Æ»s¡BÀx¦s¡B¶Ç¼½©ÎÂà¸ü¡A¥»¤¤¤ß«O¯d¤@¤Áªk«ß°l¶DÅv§Q¡C